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Abstract
The purpose of this study was to differentiate between
asthmatics whose daily symptoms are related to daily stress
level (stress responders) and those whose symptoms have no
apparent relation to stress (stress nonresponders) and to
identify differences between the two groups.

Using

correlational procedures, 15 stress responders and 19
stress nonresponders were identified and compared along
various dimensions.

Multivariate analysis of variance

(MANOVA) and covariance (MANCOVA) procedures revealed no
significant differences between the two groups with respect
to affective/emotional responding, clinical symptomatology,
or cognitions about illness and asthma.

In addition,

regression models using the Asthma Symptom Checklist PanicFear subscale, a measure of depression, and a measure of
anxiety were unable to successfully predict asthma symptom
severity.

Discriminant analyses also showed that these

variables were unable to successfully differentiate between
the two groups.

These results call into question the

validity of the responder/nonresponder distinction.

There

is a need however, for a more comprehensive assessment
measuring physiological, psychophysiological, and other
dimensions of responding before abandoning research on this
distinction.

This idea, along with other ideas for future

research are discussed.
v

Introduction
Bronchial asthma is a chronic, disabling disorder
affecting many Americans.

Epidemiological data indicate

that 8.9 million Americans are afflicted with the disease
(NIAID Task Force, 1979).

Approximately 7% of the total

population either has had asthma in the past or is
currently afflicted.
is enormous.

The financial burden of the disease

The total costs directly attributable to

asthma have been estimated to be $1.3 billion per year
(Cooper, 1976).

In attempting to manage this disease,

families typically spend 2-30% of their total income (Vance
& Taylor, 1971).

Thus, at times, the financial burden can

be overwhelming.
In addition to being financially handicapping, asthma
is extremely disabling.

Problems related to asthma result

in 27 million physician visits per year (Davis, 1972).

In

children under age 17, asthma represents the leading cause
of activity restriction (National Center for Health
Statistics, 1971).

Approximately 7 million school days per

year are lost to asthma (Davis, 1972).

This represents

about 25% of the total number of school days lost (Schiffer
& Hunt, 1963).
dramatic.

In adults, the effects are just as

Asthma accounts for the loss of 5 million work
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days per year (Davis, 1972).

In addition, many individuals

may be limited in the type of occupation they may choose to
pursue and may be limited in where they can live (Rainwater
& Alexander, 1982).

Asthma is very disruptive to the

overall functioning of families, and the lives of family
members often revolve around the patient's illness.

Asthma

has even been linked to the occurrence of divorce (NIAID,
1979).

Therefore, in addition to the many economic burdens

placed on asthmatics, this disease has a major impact upon
their quality of life and may directly affect interpersonal
relationships.
Because of the substantial economic burdens of asthma
and the adverse effects it has on a patient's quality of
life, much research has been generated in an effort to
establish the causes of asthma and appropriate treatments.
Research has discovered that the basic physiological defect
in asthma is hyperreactivity of the bronchial muscles
(Curry, 1946).

This hyperreactivity is an inherited

characteristic (Bronsky & Ellis, 1969).

However,

environmental stimuli can also induce bronchial
hyperreactivity.

In fact, hyperreactivity of the bronchial

muscles can result simply from the recurrence of
bronchospasms (Burrows, 1979).

3

An asthma attack occurs when certain provocative
stimuli are encountered by an individual with hyperreactive
airways (Van Arsdel, 1985).

A variety of provocative

stimuli have been implicated including specific allergens
and irritant particles (e.g. dust), bronchial infections,
certain pharmacologic agents, psychological factors, and
vigorous exercise (Reed, 1975).
of the most prominent factors.

Inhaled allergens are some
They typically produce an

immediate allergic reaction in the airways resulting in
bronchoconstriction.

This bronchoconstriction is the

result of the release of chemical mediators by mast cells
located in the bronchi (Austin & Orange, 1975; Henderson &
Kaliner, 1978; Matte, 1976; Parker, 1979).

The specific

chemical mediators important in the production of asthmatic
symptoms are still undetermined.
The primary pharmacologic agents that frequently
produce asthma attacks are, not surprisingly,
bronchoconstrictors.

Asthmatic individuals are much more

susceptible to bronchoconstrictor medication than are
normal individuals and thus, respiratory responses to
bronchoconstrictor agents are often used as a measure of
bronchial reactivity (Benson, 1975).

Additionally,

aspirin, beta blocker medications, and certain foods,
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especially those with yellow coloring agents, may induce
bronchoconstriction in an asthmatic (Aaronson, 1980).
Despite the fact that there are potentially many
medical causes, psychological factors have been implicated
for many years.

Depression is frequently cited as a common

associated symptom (Thompson & Thompson, 1984), but its
role as a possible etiological factor is unclear.

Anxiety

and stress have long been considered to play a major
etiological role in asthma as well as being a consequent of
having the disease (Rainwater & Alexander, 1982).

Several

studies have been designed to validate the role of these
factors.

Definitive conclusions have been impossible to

make, however, because of numerous inconsistencies within
the relevant literature (Spittle & Sears, 1984).

While

some studies find evidence in favor of anxiety as a
possible etiological factor (e.g., Dekker, Barendregy, & De
Vries, 1961), others have not (e.g., Rosenthal, Aitken, &
Zealley, 1973).
Most of the stress studies have indicated that a
positive association between stress and asthma symptom
severity exists, but inconsistencies within some studies
have led to the postulation that while a subsample of
asthmatics may respond to stress with increased breathing
difficulties, many others may be essentially unaffected by

5

stressful situations (Kinsman, Dirks, Jones, & Dahlem,
1980).

This paper reviews the relevant literature with

regard to stress, anxiety, and asthma, and proposes a study
designed to test for possible differences in various
aspects of functioning between those identified as stress
responder asthmatics and those asthmatics found to be
unresponsive to stress.
Medical Management of Asthma
The physical symptoms of an asthma attack include
wheezing (the cardinal symptom), coughing, dyspnea, and
cyanosis.

Treatment of an acute asthma attack is usually

through the use of bronchodilators (Fischl, 1985).
However, more severe attacks often require treatment with
steroids as well.

Although these palliative treatments are

usually effective in alleviating the acute attack, therapy
with asthmatics is primarily preventive, because a
prolonged remission is often helpful in reducing the
occurrence of future attacks, partly because of a reduction
in t h e .reactivity of the airways (Burrows, 1979).
One of the primary preventive measures is to avoid
contact with stimuli that elicit asthma attacks (Hackney &
Linn, 1985).

Certain stimuli aggravate most asthmatics.

These include tobacco smoke and dust.

In addition, some

individuals may respond to other specific stimuli as well.
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However, the identification of specific allergens is very
difficult and time consuming, and the reliability of the
tests used to determine specific sensitivities is
questionable (Merrett & Merrett, 1979; Vanto, 1982).

Even

if specific allergens are identified, avoidance of the
stimuli may not be a viable alternative, either because of
the nature and ubiquity of the stimuli or because of the
number of stimuli to which an individual may be sensitive.
In some individuals for whom relatively few stimuli are
responsible for the majority of the attacks, immunotherapy
(also referred to as hyposensitization or antiallergic
therapy) may be attempted (Lichtenstein, 1978).

This

therapy consists of injecting progressively larger amounts
of the allergen to which the individual is sensitive such
that the body can slowly build up antibodies to counteract
the effects of the allergen.

However, this type of

treatment is very expensive, takes several weeks to
complete, and the efficacy of this procedure has yet to be
established (Knauer, Kagey-Sobotka, & Lichtenstein, 1985).
Given the above problems, the primary mode of
treatment has been pharmacotherapy, and the main type of
medication used is the class of drugs known as
bronchodilators (Burrows, 1979).

These medications have

their effectiveness because they inhibit the production of
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chemical mediators and reduce bronchial muscle
contractility.

These medications are frequently abused,

however, often resulting in a refractoriness to the
medication and in potentially dangerous cardiac arrythmias
(Alberts & Moser, 1985).

When bronchodilators are not

effective in preventing the recurrence of attacks,
adrenocortical hormones (i.e. steroids) are occasionally
used (Hahn & Harding, 1980).
for only a few days.

Generally, steroids are given

Some asthmatics, however, due to the

severity of their problems must remain on steroids in order
to maintain pulmonary functioning reasonably close to
normal (Fallers & Ellis, 1965).

Another medication used

occasionally in the prevention of asthma attacks is
disodium cromoglycate (Cromolyn), which has its therapeutic
effects by stabilizing mast cells, thereby inhibiting the
release of mediators (Atkins, Norman, & Zweiman, 1978).
Cromolyn has been shown to be effective in some
individuals.

However, in order to be effective, it must be

inhaled three or four times daily.

In addition, a trial

period of 8 to 12 weeks is necessary in order to determine
its effectiveness for an individual (Bernstein, 1985).
complexity of this regimen reduces the likelihood of
adherence to it.

Thus, it is used much less frequently

than the other medications.

The

8

Psychological Factors in Asthma
Despite the availability of several medical treatment
methods, asthma has continued to be a difficult disease to
manage.

One of the factors complicating the management of

asthma is the relation between emotions and asthma.

As

early as the twelfth century, the physician Maimonides
referred to the role of emotions in asthmatic
symptomatology (Munter, 1968).

Because of this,

psychologists have been actively involved in attempting to
help manage the disorder by treating the emotional
components.

One of the important emotional complications

frequently associated with asthma is depression (Thompson &
Thompson, 1984).

This is not unusual, however, because

depression often is associated with medical illness.
Whereas the incidence of depression in the general
population is approximately 4.3% (Weissman & Meyers, 1978),
the incidence of diagnosable depression in medically ill
patients may be as high as 58% (Nielson & Williams, 1980).
Although this figure may be artificially high due to the
fact that depression and medical diseases often have many
symptoms in common, there is little doubt that having a
severe illness can result in dysphoria and depressed affect
(Frerichs, Aneshenesel, Yokopenia, & Clark, 1982).

9

In asthma, as in other severe chronic medical
illnesses, depression is likely linked to the threat of
death, decreased ability to engage in many of the patient's
usual activities, and disrupted interpersonal relations
(Klerman, 1981).

Depression among asthmatics may lead to a

decrease in compliance to medical recommendations and
decreases the probability of effective medical management
(Stein, 1981).

In addition, depression may lead to

increased medical utilization and a decrease in the ability
to effectively cope with stressful situations (Dirks,
Jones, & Kinsman, 1977).

Thus, while depression among

asthmatics may be a problem of its own, it also makes
effective treatment more difficult.
Anxiety/Stress Theories
Despite the importance of depression in chronic
illness in general, and with respect to asthma in
particular, most of the psychological research in asthma
has focused on anxiety, stress, and classical conditioning
as major complicating factors.

This is largely due to the

fact that they are hypothesized to play a primary role as
causative agents in asthma (Erskine-Millis & Schonell,
1981).

In addition, it has previously been suggested that

anxiety frequently accompanies an acute asthma attack
(Trueting & Ripley, 1948).

The hypothesis is that through

classical conditioning processes (i.e. the repeated pairing
of conditioned and unconditioned stimuli), the anxiety
accompanying the asthma attack becomes conditioned to the
asthma attack, and stimuli in the environment at the time
of the attack may also become conditioned stimuli
(Turnbull, 1962).

The unconditioned stimulus (UCS) in this

case would be the dust, pollen, or tobacco smoke which
elicited the initial asthma attack, the unconditioned
response (UCR).

The anxiety and environmental stimuli

which accompany the attack become conditioned stimuli (CS)
which become, by virtue of the conditioning process,
capable of producing an asthma attack (CR).

A vicious

cycle is thereby established where anxiety or the
conditioned environmental stimuli may produce an asthma
attack, which can then become conditioned to even more
environmental stimuli (Franks and Leigh, 1959; Turnbull,
1962).

As the attacks continue to occur in a variety of

settings, the range of stimuli increases until the
individual is conditioned to respond to several stimuli
with an asthma attack (Khan, 1974a, 1974b).

Stressors in

the environment are thought to contribute by increasing the
state of anxiety as one part of the stress response.
There is a substantial amount of experimental data to
support the above hypothesis.

Laboratory studies have

shown that respiratory changes representing asthmatic
behavior can be easily conditioned in both animals and man
(Dekker & Groen, 1956; Gantt, 1944; Liddell, 1951;
Ottenberg, Stein, Lewis, & Hamilton, 1958) and that
conditioning can occur in as few as five pairings (NoelppEschenhagen & Noelpp, 1954).

A hypothesis that these

changes may be amenable to stimulus generalization and
higher order conditioning (Turnbull, 1962) has also been
confirmed with the use of experimental studies (Dekker,
Pelser, & Groen, 1957; Gantt, 1964; Ottenberg et al., 1958;
Vaughan, 1939).

In addition, clinical research data have

shown that asthmatics may become conditioned to
environmental situations (Herxheimer, 1953) and that higher
order conditioning in man likely involves emotional factors
(e.g. anxiety; Wolf & Holmes, 1950).

Thus, it has been

established that anxiety and conditioning principles are
likely to play an important role in the exhibition of
asthma symptoms.
Psychological Treatment Techniques.

Much of the research

in the area of asthma has focused on classical conditioning
and anxiety as major complicating factors, and most of the
current treatment techniques have reflected this emphasis.
In an effort to treat the conditioning directly, some
investigators have evaluated a two phase treatment
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technique designed to "countercondition" the asthma
attacks.

During the first phase, the subject is told to

attempt to decrease airways resistance by a predetermined
amount during each of three trials.

Subject are given

feedback regarding performance and then is given social
reward (i.e. praise) for each successful attempt.
Theoretically, the conditioning aspect is the association
of decreased airways resistance with the praise.

During

the second phase, a mild bronchoconstriction is induced and
the subject is instructed to relax and to decrease airways
resistance until baseline levels are reached.

In one

study, a group treated with the counterconditioning method
had significant reductions in the amount of medication
taken, number of emergency room visits, and number of
asthma attacks when compared to a no-treatment control
group (Khan, Staerk, & Bonk, 1974).

However, attempts to

replicate these findings have failed (Danker, Miklich,
Pratt, & Creer, 1975; Khan, 1977).
Other treatment techniques have attempted to directly
decrease the anxiety that is presumed to be associated with
asthma attacks. It is hypothesized that this will reduce
respiratory resistance and thereby reduce the frequency and
severity of asthma attacks.

Relaxation training is the

most popular method and several studies have attempted to

test its efficacy (Alexander, 1972; Alexander, Cropp, &
Chai, 1979; Alexander, Miklich, & Hershkoff, 1972; Erskine
& Schonell, 1979; Erskine-Millis & Schonell, 1981; Phillip,
Wilde, & Day, 1972).

One of the first studies utilizing

this technique showed that children in a relaxation treated
group evidenced increases in pulmonary functioning measures
whereas those in a no-treatment control group did not
(Alexander, 1972).

However, the pulmonary measures used

were effort-dependent (highly dependent upon the patient's
physical effort) and may not have accurately reflected true
pulmonary functioning of the asthmatics due to variance
contributed by patient expectation and/or patient
cooperation.

A later study (Alexander, Cropp, & Chai,

1979) revealed that although relaxation was again shown to
produce changes in effort-dependent measures of pulmonary
functioning, there were no changes evidenced in effort
independent measures (measures independent of the patients'
physical effort).

Thus, the efficacy of progressive

muscular relaxation remains questionable.
Relaxation assisted by EMG biofeedback has also been
tested in several studies.

One study showed that an EMG

biofeedback group showed significant changes in pulmonary
functioning when compared to a group receiving Jacobsonian
relaxation and a no-treatment, control group (Davis,
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Saunders, Creer, & Chai, 1973).

However, they found it to

be effective for only those asthmatics not receiving
steroid medications.

A later study supported the

effectiveness of biofeedback by showing that an EMG
biofeedback treated group produced significantly greater
therapeutic differences than either a no-treatment control
group or a group receiving false feedback (Kotses, Glaus,
Crawford, Edwards, & Scherr, 1976).

Other studies have

also reported significant therapeutic effects attributed to
biofeedback (Kotses, Glaus, Bricel, Edwards, & Crawford,
1978).

However, despite the consistency of positive

results, biofeedback treatments have produced relatively
little change in the pulmonary functioning of the treated
patients.

Biofeedback treatments have resulted in

increases in pulmonary function of only 3% whereas it is
generally recognized that changes of 15% are necessary for
any clinically meaningful results to be produced (Keeffe,
1984).

Therefore, the clinical efficacy of biofeedback

remains questionable.
Systematic desensitization methods have produced
conflicting results.

In an initial study utilizing these

methods, desensitization increased pulmonary functioning
significantly greater than did either a relaxation group or
a group that received relaxation plus the suggestion that
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they would improve in certain specific ways (i.e. increased
pulmonary functioning, decreased respiratory problems;
Moore, 1965). However, there were no differences between
the groups on the self-reported number of asthma attacks.
A later study (Yorkston, McHugh, Brady, Serber, & Sergeant,
1974) confirmed the superiority of desensitization by
showing that pulmonary functioning significantly increased
and medication usage significantly decreased for the
desensitization group as compared to a group treated with
relaxation.

However, there were no changes on the

patients' ratings of their symptoms.

Additionally,

although both groups improved on subjective ratings by both
therapists and patients, there were no significant
differences between the groups.

A follow-up study showed

that asthmatics given steroids benefited from
desensitization whereas those not given steroids received
no therapeutic benefit (Yorkston, Eckert, McHugh,
Philander, & Blumenthal, 1979).

Thus, several studies have

indicated the potential benefits of desensitization.
However, the efficacy of this procedure has not gone
unquestioned.

In fact, one study found that controls rated

their symptom frequency as more improved than did members
of a desensitization group (Miklich, Renne, Creer,
Alexander, Chai, Davis, Hoffman, & Danker-Brown, 1977).
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This was found both during treatment and at a 10-week
followup.

Therefore, the overall evidence on the

effectiveness of desensitization is inconclusive.
Assessment Studies.

Despite the relatively large number of

treatment studies and treatment techniques within the
psychological literature, relatively few assessment studies
have tested the theoretical hypotheses.

The studies that

have been conducted yielded inconsistent results.

Of most

theoretical importance are the studies that have attempted
to assess the role of anxiety and stress in asthma.

This

is because the prevailing psychological theory is that
stress and/or anxiety can initiate or exacerbate an asthma
attack.

However, research studies designed to test this

theory have reported conflicting results.
Results from studies using several different
techniques have shown that some asthmatics are more anxious
than nonasthmatics.

Studies supporting this position have

utilized observer rating scales (Rees, 1956), neuroticism
scales,(Dekker, Barendregy, & De Vries, 1961), and
psychiatric interviews (Teiramaa, 1978).

However, several

other studies have found no differences between asthmatics
and a normal control group (c.f., Franks & Leigh, 1956;
Rosenthal, Aitken, & Zealley, 1973) on measures of anxiety.
Within the stress literature, most of the studies have
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consistently indicated that emotions and life stresses can
affect the severity of asthma symptoms.

This has been

indicated both in laboratory studies (Aitken, Zealley, &
Rosenthal, 1969; Miklich, Rewey, Weiss, & Kolton, 1973),
and in studies which have used measures of major life
events (Araujo, Arsdell, Holmes, & Dudley, 1973).

However,

a recent study utilizing a clinical interview, a rating
form completed by the interviewer (the Brief Psychiatric
Rating Scale), and a self-report inventory (the Edwards
Personal Preference Schedule) has offered evidence
contradictory to this (Spittle & Sears, 1984).
Additionally, another study found that although the number
of life stresses (as measured by a checklist of current
problems) was related to self-reported measures of asthma
symptoms, traditional medical measures of asthma severity
(i.e. physician ratings, pulmonary function tests) were not
associated with the amount of stress (Plutchik, Williams,
Jerrett, Karasu, & Kane, 1978).

Thus, the relation between

anxiety and asthma has remained extremely controversial,
and although most studies agree that there is a significant
positive relation between stress and asthma, some studies
have found contradictory evidence.
There are two major problems with most all of the
studies which have attempted to assess the relation of
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stress or anxiety with asthma.

First, most of the anxiety

studies measure a "trait" anxiety and relate that to the
severity of an individual's asthma.

Second, the stress

studies have typically measured the major life events that
have occurred in the past six months or one year of each
individual's life and related this to their asthma
severity.

The problem with this approach is that asthma

symptoms do not remain stable within an individual (and
thus would not be expected to consistently be related to
any trait measure) nor do they vary only six months or one
year at a time.
basis.

Asthma symptoms vary on a day-to-day

Thus, if one is to establish a relational pattern

between stress or anxiety and asthma symptom severity,
these variables would have to be measured repeatedly and
concurrently.
Two recent studies recognized this problem and
attempted to address these concerns.

The first study

(Goreczny, Brantley, Buss, & Waters, 1988) measured six
signs and symptoms of asthma severity via self-monitoring
techniques.

These six variables included the quality of

sleep, amount of wheezing, amount of coughing, interference
with daily routine, amount of activity restriction, and a
subjective rating of overall discomfort.

In addition,

daily measures of stress and anxiety were collected using
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self-report inventories designed for this purpose.

Results

of this study indicated that four of the six variables (all
but quality of sleep and overall discomfort) were
significantly related to daily levels of stress.

High

stress days were associated with greater symptom severity.
However, asthma symptom severity was not significantly
different between days of high anxiety and days of low
anxiety.

Results from the anxiety analyses did approach

significance though, and there was noted to be a great deal
of individual variability.
One of the shortcomings of this study was its reliance
on self-report to measure symptom severity.

A recent study

(Nathan, Brantley, Goreczny, & Jones, 1988) corrected this
deficit by using both self-reported asthma symptoms as well
as objective measures of daily pulmonary functioning.
addition, daily stress and anxiety were measured.

In

Results

of this study confirmed the relation between stress and
increased asthma severity based upon self-report measures.
However, objective measures of pulmonary functioning were
not related to the amount of stress.

Other results of this

study suggest that anxiety is related to asthma symptom
severity, though the relation is not as strong as that
between stress and asthma.
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Both studies are consistent with many previous studies
in that they supported the theory that stress and asthma
symptom severity are associated.

However, as previously

noted, although the majority of studies support this
theory, some important inconsistencies have emerged.

One

of the most commonly reported inconsistencies is the degree
to which asthmatics may respond to stressful or emotional
stimuli.

The heterogeneity of asthmatics and the

realization that there may be subgroups of asthmatics who
have stress precipitated attacks versus those who do not
has long been recognized (Rackemann, 1928).

However, the

differences between these groups along various dimensions
is an area that has received relatively little empirically
validated research.

This is surprising considering the

relatively large number of studies that have compiled
sufficient data to indicate that asthmatics do not
uniformly respond to stress in the same manner (Kinsman,
Dirks, Jones, & Dahlem, 1980).
Laboratory studies employing the threat of inducing an
asthma attack as the stressor have consistently shown that
while some asthmatics respond to the stressor with
increased breathing difficulties, many others do not
(Luparello, Leist, Lourie, & Sweet, 1970; Luparello, Lyons,
Bleecker, & McFadden, 1968; Luparello, McFadden, Lyons, &
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Bleecker, 1971; McFadden, Luparello, Lyons, & Bleecker,
1969).

This may be due to the fact that there is a

tendency for individual subjects to respond to sensory
stimulation in only one physiological modality, a concept
called response stereotypy (Lacey, Bateman, & Van Lehn,
1953; Lacey & Lacey, 1958).

For instance, one subject

might respond to stimuli with an increase in airways
resistance while another might respond with an increase in
heart rate.

The laboratory results on asthmatics cited

above have been validated by investigators from different
research laboratories (c.f., Phillip, Wilde, & Day, 1972;
Spector, Luparello, Kopetsky, Souhrada, & Kinsman, 1976;
Strupp, Levenson, Manuck, Snell, Hinrichsen, & Boyd, 1974).
Depending upon the study and laboratory cited, the number
of stress responders ranges from one-third to two-thirds of
the study sample (Kinsman et al., 1980).
Utilizing methods other than the laboratory studies
described above, additional studies have also shown that
although some asthmatics should be classified as stress
responders, another group appears to be unaffected by
stress.

For example, 20% of asthmatics responded

positively to a hypnotic suggestion that they would
experience an episode of bronchospasm (Khan, Staerk, &
Bonk, 1974) and approximately 45% of subjects acknowledged
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in interviews that stress/emotions have in the past
precipitated some of their asthma attacks (Aitken, Zealley,
& Rosenthal, 1969; Kahn, Staerk, & Bonk, 1974).
Additionally, one study showed that different subgroups of
subjects who received approximately the same scores on a
major life events scale (one measure of stress) differed
significantly with respect to the severity of their asthma
symptoms (Araujo, Arsdel, Holmes, & Dudley, 1973).

Thus,

these studies provide an extensive amount of evidence to
indicate that asthmatics differ in their susceptibility to
stress mediated asthma attacks.

In addition to explaining

the inconsistencies in the assessment studies, this may
help to explain the inconsistent and generally poor results
obtained from treatment studies which employ anxiety
reduction or stress management programs.

Although these

programs may have helped to alleviate problems for some of
the asthmatics, the results of the studies may be obscured
by the inclusion of subjects who do not benefit from the
program.
A second inconsistency within the stress/asthma
literature is the divergence of measurements of asthma
severity using self-report of the patients and those using
standard medical tests.

The reason for this divergence is

unclear, but it has been validated by different groups of
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investigators (Nathan, Brantley, Goreczny, & Jones, 1988;
Purcel et al., 1978) and is in agreement with the vast
majority of previous research.

Self-report of asthma

symptomatology is consistently related to measures of
stress.

Studies assessing the relation between traditional

medical measures of asthma severity and stress have
reported inconsistent results, largely due to the
instability of the medical measures (Burrows, 1979).

Thus,

self-report measures of asthma related problems take on an
important role as one of the primary assessment
instruments.
Illness Related Cognitions
One very important aspect of illness symptomatology often
overlooked is the patient's self-report of their attitudes
and cognitions towards illness.

Until recently, these

variables have received relatively little attention in the
research literature.

However, the small amount of existing

data does indicate that cognitive factors are likely to
influence health and illness in several ways.

First,

cognitive stimuli are able to elicit physiological changes
that mimic or reproduce the pathological changes associated
with specific disease states (Dekker & Groen, 1956; Wolf &
Goodell, 1968).

For example, in one study (Dekker & Groen,

1956), asthmatics were asked to visualize situations that
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had produced asthmatic attacks in the past.

This cognitive

process of visualization was able to produce full-blown
asthma attacks in the laboratory setting without exposure
to any allergens.
Second, there is a considerable amount of evidence
that patients' reports about their attitudes toward their
illness play a substantial role in the severity of their
illness and are significantly related to treatment outcome
measures (Smith & Apfeldorf, 1975; Turk, 1979).

Cognitive

coping strategies among myocardial infarction patients have
been shown to be related to the degree of disability
experienced (Klein, Dean, & Willson, 1965) as well as their
chances of survival (Pranulis, 1975; Klein, 1975).

A

similar relation has been shown to exist for surgery
patients (Cohen & Lazarus, 1973).
Finally, the course of action an individual takes
regarding his/her health is not dependent upon the presence
of specific symptoms, but rather upon the patient's
appraisal and interpretation of those symptoms
(Meichenbaum, 1977; Rodin, 1978).

It has been estimated

that as many as 70% of all myocardial infarction patients
misinterpret or deny the source of their symptoms (Gentry,
1975).

Denial was also found to be a common way women

coped with the discovery of breast lumps that signaled the
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possibility of breast cancer (Katz, Weiner, Gallagher, &
Heilman, 1970).

The importance of this cognitive appraisal

should not be underestimated.

A delay in seeking medical

advice can have disastrous consequences (e.g., metastasis
of cancer to other body parts, an increased amount of
affected heart tissue in a heart attack).

Therefore, an

individual's interpretation of physical symptoms and
his/her attitudes toward illness may affect behavior and
subsequent health.
Despite the presumed importance of cognitive factors
in bronchial asthma (Dekker & Groen, 1956; Munter, 1968),
very little known about these factors and how they relate
to asthmatic functioning.

Primarily, this is because until

recently, no measurement instrument existed that could
assess the cognitive functioning of asthmatic patients in a
reliable and valid manner.

In order to address this

problem, a group of investigators designed two self-report
instruments: the Asthma Symptom Checklist (ASC) and the
Respiratory Illness Opinion Survey (RIOS).
The Respiratory Illness Opinion Survey (RIOS) measures
certain specific attitudes that asthma patients may have
regarding their illness (e.g. optimism about successful
management of the illness, attitudes and expectations about
their role and the role of medical staff in their
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treatment).

One hundred nine statements regarding

respiratory illness, health care, and hospitalization (e.g.
"My health is in the hands of others.") were developed and
selected by four psychologists involved in the treatment of
asthma.

These statements were then administered to a group

of asthmatics and subjected to item analysis and cluster
analysis.

Statements judged to be inadequate by the item

analysis (e.g. poor test-retest reliability, limited
response range) or failed to add significantly to the
cluster solution were dropped, leaving 36 statements
defining five primary attitudinal clusters: Optimism,
Negative Staff Regard, Specific Internal Awareness (of
their body functioning), External Control, and
Psychological Stigma (associated with asthma).

The scale

has been shown to possess adequate reliability and validity
(Kinsman, Jones, Matus, & Schum, 1976) and subscale scores
accurately predict medical and therapeutic outcomes
(Staudenmayer, Kinsman, & Jones, 1978).

For example,

patients with low scores on subscales Negative Staff
Regard, External Control, and Psychological Stigma tended
to be given a more intense drug regimen upon discharge from
the hospital.

On the other hand, those with low Optimism

scores were more likely to judge their illness as being
severe and creating substantial interference in their
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normal daily routine.
rehospitalized.

They were also more likely to be

Similar results have been obtained in a

cross cultural study with Dutch asthmatics (Kaptein, 1982).
The Asthma Symptom Checklist (ASC) is composed of a
list of 50 symptoms that may occur during an asthma attack.
Initial selection of symptoms was based on interviews with
asthmatic patients who were asked to describe their
symptomatology during an asthma attack.

The original list

of 77 symptoms was given to a group of asthmatics who rated
the frequency of occurrence of each symptom.

Those data

were then subjected to item analysis and cluster analysis.
Items that did not load on any of the identified clusters
were discarded.

The final checklist of symptoms has been

shown to have adequate reliability and validity (Kinsman,
Luparello, O'Banion, & Spector, 1973; Kinsman, Spector,
Shucard, & Luparello, 1974) and consists of five clusters:
panic-fear, irritability, fatigue, bronchoconstriction, and
hyperventilation-hypocapnia.
One of the five subscales (i.e., panic-fear) has
consistently been shown to be related to functional
measures of impairment among asthmatics.

It is related to

the intensity of drug treatment two to six months after
discharge from the hospital (Kinsman et al., 1977), patient
initiated requests for as-needed (PRN) respiratory
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medications (Dahlem, Kinsman, & horton, 1977), and rates of
rehospitalization (Staudenmayer, et al., 1979).

The panic-

fear scale is hypothesized to be a measure of anxiety.
However, rather than reflecting a degree of general
anxiety, the ASC panic-fear scale measures the amount of
illness- specific anxiety.

It is used as an aid to help

assess the degree of panic associated with asthma attacks
and is only minimally related to characterological or trait
anxiety (Pearson product-moment r = 0.34) as measured by
the Taylor Manifest Anxiety Scale (Kinsman, Dirks, Dahlem,
& Heller, 1980).
The ASC and RIOS have been combined with the Minnesota
Multiphasic Personality Inventory (MMPI; a measure
frequently used to assess emotional and psychological
factors in chronic illness populations) in several
assessment studies.

This combination has been shown to be

effective in predicting rehospitalization rates of
asthmatics with correct predictions ranging from 70% to 84%
(Dirks, 1982; Dirks & Kinsman, 1981).

Also, patients with

different patterns of compliance/noncompliance to as needed
(PRN) medications have been shown to produce different
patterns of scores on these three measures (Kinsman, Dirks,
& Dahlem, 1980).

Thus, the ASC and RIOS have provided a
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significant amount of data that attest to their usefulness
as valid indicators of asthmatic functioning.
Purpose of this Study
The issue of stress reactivity and its measurement has
become a major area of research in the past few years.

In

fact, recently the United States Department of Health and
Human Services was involved in the sponsorship of a
conference devoted solely to stress, stress reactivity, and
implications for cardiovascular disease (Weiss, Mathews,
Detre, & Graeff, 1984).

However, there have been no

studies which address the issue of stress reactivity and
stress responders among asthmatics.

Given the evidence

that stress is associated with the severity of asthma
attacks (Goreczny, Brantley, Buss, & Waters, 1988; Nathan,
Brantley, Goreczny, & Jones, 1988), this issue becomes even
more important.

Not only is it important to differentiate

stress responders from nonresponders for theoretical
reasons, but also for the implementation of successful
treatment techniques.

Thus, the successful and efficient

identification of stress responders and the elucidation of
ways in which stress responders and stress nonresponders
differ may be important for improving therapy.
The suggestion that stress level is associated with
asthma attack severity has received continued support.

It
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was not until recently however, that this association was
clearly established (Goreczny, Brantley, Buss, & Waters,
1988).

Additionally, it appears, as would be expected,

that the effects of stress vary from individual to
individual.

The notion of individual differences between

asthmatics in response to stress has previously been
addressed (c.f., Kinsman et al., 1980), but this area is
insufficiently researched.

In addition, although stress

may have several different effects involving changes in
disease severity, in self-report of affective changes, and
in self-report of cognitive alterations (Bradley & Prokop,
1982; Burish, 1981), these effects are not well delineated.
Given the association of stress with asthma severity,
it is also possible that those individuals who have stress
associated asthma attacks also have changes in the areas
noted above.

However, the differences within an illness

population between stress responders and stress
nonresponders have never been adequately studied.

The

elucidation of these differences may aid in a more
comprehensive understanding of the relation between stress
and illness, may provide information and a rationale to
account for differences in stress responsiveness, and may
suggest appropriate interventions to aid in the treatment
of stress related asthma attacks.

The purpose of the
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present study was to assess if there are any differences in
affective/emotional functioning, asthma related
symptomatology, or cognitions about their illness between
asthmatics with stress related symptomatology and those
with asthma which is unresponsive to stress.
Given what is known about the interaction of stress
with asthma, the following hypotheses were asserted:
1)

Several studies have shown that asthmatics differ

in the degree to which they respond to stress (c.f.,
Spector, et al., 1976).

Although no one has yet

proposed an adequate way of classifying individuals
into stress responder versus stress nonresponder
groups, there is a significant amount of data to
indicate that such a grouping is warranted (c.f.,
Khan, et al., 1974).

In addition, recent research has

demonstrated that self-monitoring of the clinical
asthma symptomatology appears to be responsive to
changes in the amount of daily life stressors
(Goreczny et al, in press; Nathan et al., 1988).
Therefore, it was hypothesized that asthmatics would
be able to be identified as stress responders or
stress nonresponders on the basis of self-monitoring
of their asthma symptomatology.

32

It was also hypothesized that stress responders and stress
nonresponders would differ in a variety of ways:
2)

Affective/emotional functioning.

The occurrence

of daily stressors is extremely unpredictable and
therefore uncontrollable.

It has been shown that the

unpredictable stressors have the more adverse effects
upon an individual's functioning (Glass, Singer, &
Friedman, 1969).

Part of the reason for this may be

the unexpectable nature of the stressor.

This often

leads to emotional responding (Glass, Heim, & Singer,
1971) and may thus account for the negative emotional
states produced by stress (Braun & Linder, 1979;
Stoyva & Anderson, 1982).

Therefore, it was

hypothesized that those individuals who have stress
mediated asthma attacks would evidence more emotional
distress (i.e., depression, anxiety) than those who do
not have stress mediated asthma attacks.
3)

Disease specific problems.

It has been clearly

shown that at least for some asthmatics, stress level
and asthma severity are related (c.f., Goreczny, et
al., 1988; Purcel, et al., 1978).
causation can be bidirectional.

The direction of
It has been shown

that laboratory stressors can result in an asthma
attack (c.f., Luparello, et al., 1970).

However, it
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is just as possible that having an asthma attack can
result in additional environmental stressors (e.g.
wheezing and coughing creating problems completing a
task).

Because of this and the ubiquity of stress in

everyday living, it is likely that asthmatics who are
stress responders have the more severe asthma attacks.
The stress responders are more likely to have
increased respiratory difficulties during the periods
of stress than the nonresponders and thus present with
an increased number of asthma attacks.

The increased

likelihood of an asthma attack makes it more likely
that a conditioning process will exacerbate the
situation, leading to potentially more respiratory
difficulty (Franks & Leigh, 1959).

Therefore, it was

hypothesized that the stress reactors would show the
more severe asthma specific symptomatology.
4)

Associated cognitions regarding asthma.

It is

known that when people are stressed, they may
experience negative cognitions (Burish, 1981).
However, the effects of chronic stress reactivity upon
asthmatics and the cognitive components (i.e.,
attitudes) related specifically to their disease has
never been investigated.

What has been established

however, is the association of depression and negative
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cognitions (Sacco & Beck, 1985).

Because it was

hypothesized that depression would be greater in
stress responders than in nonresponders (see
Hypothesis 1) and it is known that depression is
associated with an increased amount of negative
cognitions, it was also hypothesized that stress
responders would be significantly more negative in
their attitudes and cognitions than the stress
nonresponders.
As stated earlier, the major psychological hypothesis in
asthma research concerns the role of anxiety.

Although

there has been considerable debate over the importance of
characterological or trait anxiety, illness-specific
anxiety (i.e., anxiety related directly to the fear of an
asthma attack and its consequences) has consistently been
identified as a major complicating factor in medical
management and as a predictor of medical outcome.

Thus,

several hypotheses related specifically to panic-fear may
help to elucidate the proposed relation to asthma:
5)

Because it is possible that the panic-fear scale

of the ASC, being a measure of anxiety, is related to
stress, it was also hypothesized that scores on the
panic-fear subscale would account for a large
proportion of variance in stress related

35

symptomatology.

It was also hypothesized however,

that other measures of affective/emotional responding
(i.e., depression and anxiety) would add significantly
to the amount of variance which could be predicted.
6)

Because panic, fear, stress, and anxiety are often

confused (Endler & Edwards, 1982; Speilberger, 1976),
it is possible that the panic-fear scale represents
one way of distinguishing stress responders from
stress nonresponders.

Given the difficulty in

discerning between the different concepts listed above
and their presumed, though unclear, relation to each
other (Endler & Edwards, 1982), it was hypothesized
that panic-fear would be able to significantly
discriminate between stress responders and stress
nonresponders.

It was further hypothesized that MMPI-

D and MMPI-Pt would add to the discriminatory power.
Method
Subjects.
Subjects included 15 stress responder asthmatics and
19 stress nonresponder asthmatic patients from Earl K. Long
Memorial Hospital.

Only adult subjects over age 18 were

recruited for participation in this study.

Patients were

recruited from ongoing referrals to the Pulmonary
Rehabilitation Program.

Patients are referred to this
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program by physicians and staff within the hospital.

In

order to participate in the program, subjects were required
to be diagnosed by one of the hospital physicians as having
asthma.

Diagnosis was made based upon chest x-rays,

history of complaints, pulmonary function tests, and
physical examination.

Upon admission to the Pulmonary

Rehabilitation Program, referrals were evaluated as to
their appropriateness for either the stress responder or
stress nonresponder group (see Statistical Analysis
section).

Consecutive referrals were evaluated until at

least 15 subjects per group met the qualifications for
inclusion.
Instruments.
Daily Stress Inventory (DSI).

This is a 58 item self-

report inventory designed to measure the number and
perceived impact of daaly stressors (see Appendix A).
Individuals first rate the occurrence/nonoccurrence of each
item.

Then, on those items which did occur, the

individuals rate the amount of impact they feel that it had
on them.

The perceived impact is rated on a Likert scale

ranging from 1 (occurred but was not stressful) to 7
(caused me to panic).
gradations of severity.

In between these extremes are
Two scores are then calculated: a)

Frequency, which is simply a count of the number of items
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that were reported to have occurred during the 24 hour
period, and 2) Sum, which is equal to the total of the
item-impact ratings.

The DSI has been shown to have

adequate reliability and validity (Brantley, Cocke, Jones,
& Goreczny, 1988; Brantley, Waggoner, Jones, & Rappaport,
1985) and scores on the DSI are correlated with daily
cortisol levels (Brantley, Dietz, Tulley, & Jones, 1988).
Self-Monitoring.

Previous research has shown that several

asthma symptoms, when self-monitored, appear to be
responsive to stress (Goreczny, Brantley, Buss, & Waters,
1988).

These symptoms include amount of wheezing, amount

of coughing, interference with daily routine, and number of
activities interrupted due to respiratory problems.

A

subsequent study confirmed the susceptibility of these
symptoms to the amount of perceived stress (Nathan, et al.,
1988).

Therefore, subjects will be asked to monitor these

four symptoms on a daily basis for 21 days (see Appendix
B).

Previous data on self-monitoring techniques have shown

this to be a reliable method of measurement and for
gathering data on physical signs and symptoms(Roskies,
1979; Taylor, Zlutnick, Corley, & Flora, 1980).
Asthma Symptom Checklist (ASC).

This is a 36 item

checklist consisting of a list of symptoms that are rated
on a 5 point scale of frequency of occurrence (1 = never
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and 5 = always).

The signs and symptoms on the checklist

make up 5 symptom clusters.

These include panic-fear,

irritability, fatigue, hyperventilation-hypocapnia, and
bronchoconstriction.

The scale and the clusters have been

shown to have adequate reliability and validity (Kinsman,
Luparello, O'Banion, Spector, 1973).

Internal consistency

coefficients for the five clusters are 0.93, 0.90, 0.85,
0.83, and 0.83, respectively.

Test-retest reliability

coefficients are 0.95, 0.86, 0.76, 0.78, and 0.82 for the
five respective clusters.

A later study replicated the

results of the initial five cluster solution (Kinsman,
Dahlem, Spector, & Staudenmeyer, 1977).

The use of this

scale represents an acceptable way to measure the severity
of asthma symptomatology because it is more stable than
pulmonary function tests, which can vary widely from one
reading to the next, and scores on this scale represent an
accurate way of predicting long term functioning (see
Appendix C ).
Respiratory Illness Opinion Survey (RIOS).

The RIOS is a

questionnaire consisting of 36 statements regarding
attitudes toward respiratory illness and its treatment (see
Appendix D).

Each statement is rated on a five point scale

(1 = strongly agree and 5 = strongly disagree).

A cluster

analysis identified 5 attitude categories which were
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subsequently labeled Optimism, Negative Staff Regard,
Specific Internal Awareness, External Control, and
Psychological Stigma.

This scale has been shown to have

adequate reliability and validity (Kinsman, Jones, Matus, &
Schum, 1976) and is frequently used in comprehensive
assessments of asthmatics.

Internal consistency

coefficients for each of the subscales are: Optimism (.80),
Negative Staff Regard (.84), Specific Internal Awareness
(.68), External Control (.76), and Psychological Stigma
(.82 ).
Minnesota Multiphasic Personality Inventory (MMPI).

The

MMPI is a widely used instrument useful in the assessment
of emotional and psychological factors.

It produces a

profile consisting of 3 validity scales and 10 clinical
scales.

It has been widely used to assess the

psychological factors associated with a variety of physical
disorders including chronic pain (Armentrout, Moore,
Parker, Hewett, and Feltz, 1982) and headache (Rappaport,
McAnulty* Waggoner, & Brantley, 1987).
Procedure.
Subjects attended four weekly sessions.

During the

first session, the project was explained and the subjects
were required to sign an informed consent form (see
Appendix E) before being permitted to continue.

They were
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then trained to properly complete the Daily Stress
Inventory (DSI) and self-monitoring forms on which they
recorded daily amounts of wheezing, coughing, activity
restriction, and interference with daily routine.

At the

second session, monitoring forms from the previous week
were collected, any questions regarding the monitoring were
answered, and new forms for the following week were
distributed.

The subjects were then instructed to complete

the Minnesota Multiphasic Personality Inventory (MMPI).
At the third session, monitoring forms were collected,
questions regarding these forms were answered, and new
forms were distributed.

Subjects were then instructed to

complete the Asthma Symptom Checklist (ASC) and the
Respiratory Illness Opinion Survey (RIOS).

At the fourth

and final assessment session, all subjects returned the
monitoring forms from the third week of monitoring.

Any

other questions regarding the program were answered at this
time and the subjects were instructed to call back in
approximately 3 weeks if they wish to obtain feedback on
the information they provided.
Results
The initial sample consisted of 42 asthma subjects.
Because we can study the effects of stress on illness
symptomatology only when there are active signs of the
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illness, any subject who reported no problems with asthma
symptomatology during the study period was excluded.
addition, an outlier analysis was performed.

In

Any subject

who scored more than or less than three standard deviations
from the mean on any of the four asthma symptom variables
was excluded (Tabachnick & Fidell, 1983).

Three subjects

from the original 42 were identified and eliminated from
all further analyses.

The means and standard deviations

for all variables for the remaining 39 subjects are shown
in Table 1.

An intercorrelation matrix consisting of these

variables is shown in Tables 2, 3 and 4.

In order to

assess the stress responder status of each asthmatic (i.e.,
responder versus nonresponder), a correlation matrix
consisting of the data from the daily monitoring forms was
computed for each subject individually.

The DSI-frequency

score was correlated with each of the 4 asthma symptoms
(i.e., wheezing, coughing, activity restriction, and
interference with daily routine.)

A stress responder was

defined as someone having at least two significant
correlation coefficients while a stress nonresponder was
defined as someone having no significant correlations.
Although it was initially planned to require 3 significant
correlations, the asthma symptoms did not covary enough to
permit this.

It was found that only five of the 39
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subjects met this criterion.

Thus, this criterion was

considered overly stringent and was reduced to two
significant correlations.

This new criterion allows for

acceptance of a more representative sample while still
helping to prevent the inclusion of subjects with spurious
results.

Utilizing this criterion, 15 subjects were

identified as stress responders (see Table 1) and 19
subjects as stress nonresponders (see Table 2).

Five

subjects had one significant correlation from among the
four (see Table 3).

These five subjects were excluded from

further analyses which involved group membership.
A one-way multivariate analysis of covariance
(MANCOVA) was performed to look at differences in
emotional/affective functioning between the two groups
after controlling for the average number of stressors.

The

one factor was group membership (i.e., stress responder
versus stress nonresponder), the dependent variables were
the depression and psychasthenia scores from the MMPI, and
the covariate was the average DSI-frequency score.

The

results from this analysis (see Table 4) indicated that the
multivariate effect for group membership was
nonsignificant, F (2, 29) = 0.34, £ > .10.

The

corresponding univariate ANCOVAs were also nonsignificant.
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This was the case for both MMPI-D, F (2, 30) = 0.15, £ >
.10 and MMPI-Pt, F (2, 30) = 0.37, £ > .10.
The next analysis was designed to look at differences
between the two groups in terms of their symptomatology,
number of reported stressors, and score on the ASC panicfear sclae. A one-way MANOVA was calculated with group
membership constituting the one factor.

Six variables

measuring clinical symptomatology served as the dependent
variables.

These six variables included the panic-fear

scale from the ASC, the average number of daily stressors
(as measured by the DSI and averaged over the 21 days), and
the average severity rating for each of the four monitored
respiratory symptoms (i.e., wheezing, coughing,
interference with daily routine, and amount of activity
restriction).
Table 5.

The results of the analysis is shown in

The overall group effect for these six variables

was nonsignificant, multivariate F (6, 27) = 2.22, £ > .05.
Five of the subsequent univariate ANOVAs were also
nonsignificant.

This was the case for amount of wheezing,

F (1, 32) = 1.78, £ > .10, amount of activity restriction,
F (1, 32) = 1.82, £ > .10, amount of coughing, F (1, 32) =
0.58, £ > .10, interference with daily routine, F (1, 32) =
3.87, £ > .05, and number of daily stressors, F (1, 32) =
0.92, £ > .10.

However, the univariate ANOVA for the ASC
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panic-fear scale was significant, F (1, 32) = 7.13, £ <
.02.

Stress nonresponders had significantly higher panic-

fear scores than stress responders.
In order to look at differences between the groups on
cognitive components of the disease, a multivariate
analysis of variance (MANOVA) was performed using the five
subscales from the RIOS as the dependent measures.

Results

from the MANOVA (see Table 6) revealed a nonsignificant
effect of group membership, F (5, 28) = 1.09, £ > .10.
Four of the five subscales had corresponding nonsignificant
effects for group membership.

These four scales were

optimism, F (1, 32) = 0.01, £ > .10, negative staff regard,
F (1, 32) = 0.27, £ > .10, specific internal awareness, F
(1, 32) = 0.09, £ > .10, and psychological stigma, F (1,
32) = 0.52, £ > .10.

However, there was a significant

group effect on the scale measuring external control, F (1,
32) = 5.17, £ < .03.

Stress responders had significantly

higher scores on this scale than did stress nonresponders.
Regression analyses were performed in order to
ascertain the proportion of variance in stress reactivity
for each of the four asthma symptoms that could be
accounted for by panic-fear alone and by a combination of
panic-fear, depression, and anxiety.

Two sets of four

stepwise regression equations were calculated.

The data
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for each of the dependent variables for the seven days on
which DSI frequency score was highest were added together
to obtain a high stress score for each variable.

The same

procedure was used to obtain scores for low stress days.
The low stress score for each variable was subtracted from
the high stress score for that variable.

The resulting

four scores served as the dependent variables for the four
separate regression analyses.

The first set of regression

analyses included only panic-fear as the independent
variable.
Table 7.

The results of these analyses are listed in
There were no significant effects on any of the

four equations and the amount of variance accounted for in
each of the four variables was negligible, ranging from
.25% (wheezing) to 6.2% (interference with daily routine.)
The second set of regression analyses include panic-fear,
MMPI-D, and MMPI-Pt.
listed in Table 8.

The results of these analyses are
Again, none of the regression equations

were significant at the .05 level.

However, the regression

equation on activity restriction approached significance, F
(3, 35) = 2.85, £ = .051 and accounted for 19.6% of the
variance.
Finally, two discriminant analyses were performed in
order to ascertain the ability of the panic-fear subscale
to distinguish between stress responders and stress
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nonresponders.

In the first analysis, the only predictor

used was the score on the panic-fear subscale.

In order to

reduce bias in the classification rates, a jackknifed
classification was utilized.
are shown in Table 9.

The results of this analysis

The panic-fear subscale was able to

correctly classify only 58.8% of the subjects.

The second

discriminant function computed utilized three predictors:
panic-fear, MMPI-D, and MMPI-Pt.

A jackknifed

classification was used here also.
presented in Table 10.

These results are

Only 61.8% were correctly

classified.
Discussion
The purpose of this study was to attempt to
distinguish between stress responder asthmatics and stress
nonresponder asthmatics and to assess their differential
functioning across several levels.

Given the recent

research showing that asthma symptomatology monitored on a
daily basis is related to the number of daily stressful
life events (Goreczny, et al., 1988; Nathan, et al., 1988),
the present paper attempted to distinguish between stress
responders and stress nonresponders on the basis of a
demonstrated relation between life events and respiratory
symptoms.

In the present investigation, it was found to be

possible, using correlational procedures, to distinguish
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between two groups of asthmatics: one group whose asthma
symptomatology had no relation to the number of daily
stressors and a second group who did evidence a stressasthma symptom relation.

However, results of this paper

failed to demonstrate that the two groups differ on the
dimensions measured, thereby questioning the significance
of this distinction.

This is consistent with previous

research literature.

Although there is a good rationale to

expect there to be subgroups of asthmatics (c.f., Kinsman,
et al., 1980) and several groups of investigators have
postulated the existence of subgroups (Purcel, et al.,
1968; Rackemanne, 1928), these differentiations have not
been shown to be of clinical importance.
It is possible however, that in attempting to find
differences between the groups, we have not measured the
correct variables.

In this study, three dimensions of

functioning were assessed: affective/emotional responding,
clinical symptomatology, and cognitions regarding illness
and asthma.

Using multivariate procedures, no significant

differences between the

two groups were found. The lack of

a difference between the groups on measures of
affective/emotional functioning (i.e., anxiety, depression)
may be accounted for by

the selection process. All

subjects had to have at

least minimal problems with asthma
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related symptomatology.

Having a serious chronic illness

without any necessary exacerbations (stress related or not)
is known to be associated with increased emotional distress
(Frericks, et al., 1982; Thompson & Thompson, 1984).

This

fact combined with the selection process which required
both groups to have active disease related problems may
account for the absence of any significant differences in
emotional functioning.
It was quite surprising to find no differences between
stress responders and stress nonresponders on measures of
asthma severity.

Given the conditioning process that is

presumed to play a major role among stress responder
asthmatics, it was expected that the presence of
"conditioned asthma problems" on top of the individuals'
regular asthma difficulties would have resulted in
increased clinical symptomatology for the stress
responders.

The lack of a significant difference between

these groups suggests that conditioning processes may not
be as important as once presumed.

An alternative

hypothesis however, is that conditioning processes affect
both groups independently of stress responsiveness.

These

hypotheses need further elaboration and testing in future
studies.

Given the lack of a difference between the two

groups on measures of affective/emotional responding and
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clinical symptomatology, it was not surprising to find no
differences between the groups on a measure of cognitive
dimensions related to illness and asthma.
The ASC panic-fear scale accounted for very little
variance in the difference between asthma symptomatology on
days of high stress and asthma symptomatology on days of
low stress.

The addition of anxiety and depression scores

to the regression model did add to the amount of variance
that could be accounted for but not enough to result in an
overall significant effect for the regression model.

Thus,

these scales are not predictive of differences in asthma
symptomatology as measured in this study.

In addition,

these variables were unable to successfully discriminate
between stress responders and stress nonresponders.

The

model using panic-fear alone successfully categorized only
58.8% while adding the anxiety and depression scores
increased the success rate to only 61.8%.

Therefore, these

variables appear to have limited predictive value.
While it was possible to separate out the subjects in
the study into the two groups using correlational
procedures, the asthma symptoms did not covary within
individuals.

Thus, on days of high stress, one subject

might react with more coughing and activity restriction
whereas another may react more with wheezing and
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interference in their daily routine.

This has important

implications, both clinical and theoretical.
Theoretically, the effect of response stereotypy (Lacey &
Lacey, 1958) may help to explain the differences.
According to this theory, the pattern of responsiveness is
different for each individual.

This was initially applied

to psychophysiological variables to help explain why one
individual responds to stress more with cardiovascular
changes while another responds more with pulmonary changes.
However, it appears that a similar phenomenon occurs within
a specific disease (i.e., asthma) as well as serving as an
explanation for differences between different diseases.
The different pattern of stress relatedness within
asthmatics may be of importance.

Individuals who have

stress related increases in wheezing and interference with
their daily routine as opposed to coughing and activity
restriction may be different physiologically as well as
behaviorally.

Clinically, it becomes important to measure

illness severity across different dimensions and using more
than just one symptom.

This is especially important in

asthma and other illnesses which can have numerous effects
and in which the severity of the illness is a combination
of multiple factors (e.g., diabetes, renal disease).

This

point must be kept in mind not only for this and future
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studies, but also when reading and interpreting previous
experiments which have been reported in the literature.
Studies which have found no relation between stress and
illness symptomatology (Spittle and Sears, 1984) may have
measured only one aspect of illness severity.
In conclusion, the present study indicated that
although we are able to distinguish between stress
responders and stress nonresponders on the basis of
correlations between their self-reported number of
stressors and their asthma symptoms, we were unable to
discern any significant differences between the groups.
Before additional studies in this area are conducted, there
is a basic psychometric question which needs to be
resolved: that of the reliability and validity of the
responder/nonresponder distinction.

To do this, future

studies need to first test the stability of the
distinction.

Will someone defined as a stress responder

today be so defined using data collected 1 month later, 2
months.later, or 6 months later?

Validity data could come

in the form of biochemical, psychophysiological, and other
laboratory diagnostic techniques.
Finally, it would then be important to determine the
usefulness of this distinction.

What are the differences

between the groups? Is one group more likely to have skills
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which make them better able to cope with stress while the
other to utilize medical services more frequently?
Identifying these groups without identifying any
differences between them questions the utility and validity
of the distinction.

In this paper, two univariate ANOVAs

were significant at the .05 level.

These were the ASC

panic-fear scale and the External Control scale of the
RIOS.

However, the multivariate analyses in which these

variables were included were nonsignificant, thus rendering
these scales unable to be interpreted.

Whether the

differences on these scales represents true differences
between the groups or are spurious results is a question
which needs to be addressed in future research studies.

In

addition, future studies need to define precisely what
constitutes a true increase in illness severity and what
specific symptomatology should be included.

In any event,

it seems imperative that we continue measuring multiple
aspects of functioning including physiological, behavioral,
cognitive, and emotional components.

Only in this way can

we more effectively elucidate the stress-illness relation.

Table

1

Means and Standard Deviations of all variables

Mean

S. D.

Wheeze

1.76

1 .12

Activity Restriction

1.74

0. 74

Coughing

1.98

0. 88

Interference with Routine

1.73

1. 04

Frequency of Stresors

17.63

17. 65

MMPI-D

68.74

10. 98

MMPI-Pt

64.77

12. 37

ASC Panic-Fear

2.79

0. 99

Optimism

3.46

0. 76

Neg. Staff Regard

1.86

0. 62

Internal Awareness

4.16

0. 76

External Control

2.40

0. 69

Psychological Stigma

2.49

0. 77
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Table
Intercorrelation

Amount of
Wheezing
Activity
Restriction
Amount of
Coughing

2

m a t r i x for
(n = 3 9 )

all

variables

Freq.

MMPI-D

m m p i -:

.4727
.0024

-.0374
.821 0

.1223
.4583

.2082
.2034

.7699
.0001

-.1260
.4448

.0882
.5936

.2321
.1551

.5142
.0008

-.2836
.0802

.0021
.9901

.2126
.1939

-.1562
.31 50

.1132
.4928

.2876
.0758

.0730
.6587

-.1376
.4037

Activ.

Cough

Inter.

.3128
.0525

.5409
.0004
.2558
.1006

Interference
with Routine
Freq of
Stressors

.6383
.0001

MMPI-D
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Table

3

I n t e r c o r r e l a t i o n m a t r i x fo r a l l
(n = 3 9 )

variables

ASC PF

Optim.

Nega.

Inter.

Exter.

Amount of
Wheezing

-.0025
.9879

-.1221
.4591

.2821
.0818

.1798
.2734

.2182
.1821

.0573
.7292

Activity
Restriction

-.2447
.1332

.0455
.7835

.1678
.3073

.1468
.3727

.2487
.1268

-.0105
.9493

.0634
.7013

-.1988
.2249

.3053 -.1085
.0587 .5110

.1868
.2549

.1062
.5198

Interference
with Routine

-.1576
.3379

-.0965
.5592

.3056 -.0069
.0585 .9668

.3022
.061 5

.0975
.5548

Freq- of
Stressors

-.2279
.1629

-.1716
.2962

.0741
.6538

.0443
.7889

.0478
.7725

.0503
.761 3

-.5346 -.1127 -.3439
.0005 .4944 .0321

.2384
.1439

.2968
.0665

.2120 -.2730
.1950 .0927

.5262
.0006

.4129
.0090

Amount of
Coughing

MMPI-D

.2748
.0905

MMPI-Pt

.1734
.291 3

.2903
.0730
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Stigma

Table

4

I n t e r c o r r e l a t i o n m a t r i x for
(n = 3 9 )

ASC
Panic-Fear
Optimism
Negative
Staff Regard

all

variables

Optim.

Nega.

Inter.

Exter.

Stigma

1598
.331 1

.1392
.3980

-.0371
.8225

-.2187
.1811

-.0945
.5671

.1478
.3961

.2765
.0884

-.2042
.2125

-.3842
.01 57

-.0363
.8309

.3496
.0291

.0854
.6053

-.0376
.8202

.0735
.6565

Internal
Awareness

.6201
.0001

External
Control
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Table
Correlation
for

of

5

DSI-frequency with

subjects

in

stress

asthma

responder

symptoms

group

Cough

Interference

.604*

.155

.493*

.755*

.616*

.000

.085

3

.445*

.500*

.321

.355

4

.625*

.428

.615*

.267

Sub

Wheeze

1

.382

2

5

-.090

Activity

.597*

-.456*

.597*

6

.521*

.452*

.194

.476*

7

.518*

.440*

.326

.288

8

.195

.205

.437*

.438*

9

.228

.802*

-.345

.729*

10

.448*

-.505*

.000

.447*

.521*

-.224

.470*

.580*

.051

.462*

11
12

-.053
.478*

13

-.102

.579*

.579*

-.247

14

.302

.638*

.493*

.281

15

.009

.494*

.105

.434*

* significant at the .05 level
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Table
Correlation
fo r

of

6

DSI-frequency with

subjects

in

stress

asthma

nonresponder

symptoms
group

Wheeze

Activity

Cough

1

.080

.181

.354

.026

2

.348

-.1 52

.000

.000

3

.052

.264

.185

.396

4

-.034

.204

.195

.066

5

.187

.034

.000

.000

6

-. 196

.000

.237

.000

7

.000

.351

.000

.000

8

.000

-.1 04

.000

-.094

9

.000

.000

.000

.000

10

-.144

-.279

.000

-.279

11

-.237

-.290

-.246

-.278

12

.120

-.093

.102

-.059

13

.000

-.059

.000

.204

14

.000

.041

.112

.095

15

-.122

.098

.000

.009

16

-.137

.410

.073

.000

17

-.410

.213

.401

-.232

18

.070

.202

-.101

-.044

19

-.282

.220

-.317

.311
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Interference

Table
Correlation

of

for

Sub

Wheeze

7

DSI-frequency with
subjects

in n e i t h e r

Activity

asthma
group

Cough
-.484*

-.145

symptoms

Interference
-.303

1

-.081

2

.261

.439*

.376

.118

3

.056

.556*

.219

.374

4

.462*

.405

.152

.148

-.1 52

-.062

5

-.251

.584*

* significant at the .05 level
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Table

8

MANCOVA and univariate ANCOVAS to test for differences
between stress responders and stress nonresponders on
affective/emotional measures

F value

df

p value

Overall MANOVA

3, 29

0.34

> .10

MMPI-D

2, 30

0.15

> .10

MMPI-Pt

2,

30

0.37

> .10
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Table

9

MANOVA and univariate ANOVAs to test for differences
between
stress responders and stress nonresponders on measures
of clinical symptomatology

p value

df

F value

Overall MANOVA

6, 27

2.22

.05

Wheezing

1, 32

1 .78

.10

Activity Restriction

1, 32

1 .82

.1 0

Coughing

1, 32

0.58

.10

Interference

1, 32

3.87

.05

Number of Stressors

1, 32

0.92

.1 0

ASC panic-fear

1, 32

7.13

.02
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Table

10

MANOVA and univariate ANOVAs to test for differences
between
stress responders and stress nonresponders on scores from
the subscales of the RIOS

df

F value

p value

Overall MANOVA

5, 28

1.09

> .10

Optimism

1, 32

0.01

> .10

Negative Staff Regard

1, 32

0.27

> .10

Internal Awareness

1, 32

0.09

> .10

Psychological Stigma

1/32

0.52

> .10

External Control

1, 32

5.17

< .03
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Table

11

Regression analyses using only the panic-fear scale

Variable

F Value

p value

R-Square

Wheeze

0.09

.761

.0025

Activity

1 .79

.189

.0461

Cough

0.16

.692

.0043

Interference

2.46

.126

.0623

Table

12

Regression analyses using panic-fear, MMPI-D, and MMPI-Pt

Variable

B Weight

Wheeze
panic-fear

-0.018

F Value

p value

0.12

.884

0.02

.886

MMPI-D

-0.005

0.14

.709

MMPI-Pt

-0.001

0.00

.953

2.85

.051

2.89

.098

-0.008

0.18

.676

0.036

5.07

.031

0.47

.704

Activity
panic-fear
MMPI-D
MMPI-Pt

-0.274

Cough
panic-fear

0.062

0.45

.505

MMPI-D

-0.007

0.41

.524

MMPI-Pt

-0.003

0.11

.743

1.42

.253

2.79

.104

-0.006

0.07

.791

0.022

1.46

.236

Interference
panic-fear
MMPI-D
MMPI-Pt

-0.312
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R-Square
.0103

.1965

.0387

.1085

Table

13

Discriminant analysis based on panic-fear score only
Classified into group
Responder

Nonresponder

Total

Responder

8
53.33%

7
46.67%

15
44.12%

Nonresponder

7
36.84%

12
63.16%

19
55.88%

From Group

Total

15
44.12%

65

19
55.88%

Table

14

Discriminant analysis based on panic-fear, MMPI-C , and
MMPI-PT
Classified into group
Responder

Nonresponder

Total

1
1

Responder

8
53.33%

:
I

7
46.67%

15
44.12%

13
68.42%

19
55.88%

1
1

From Group
1
1

Nonresponder

6
31.58%

i
!
1
I

Total

14
41.18%

66

20
58.82%
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Appendix A
Daily Stress Record

Date:

Subject:

Below are listed a variety of events that may be viewed as stressful or unpleasant.
Read each item carefully and decide whether or not that event occurred within the
past 24 hours. If the event did not occur, place an H X " in the space next to that
item. If the event did occur, indicate the amount of stress that it caused you by
placing a number from zero to 7 in the space next to that item (see numbers below).
Please answer as honestly as you can so that we nay obtain accurate information.
X * did not occur (past 24 hrs.)
1 ■ occurred but was not stressful
2 « caused very little stress
1. Performed poorly at task
2. Performed poorly due to others_
3. Thought about unfinished work
4. Hurried to meet deadline
5. Interrupted during task /
activity
6. Someone spoiled your completed
task
7. Did something you are
unskilled at
8. Unable to complete a task
9. Was unorganized
10. Criticized or verbally
attacked
11. Ignored by others
12. Spoke or performed in public
13. Dealt with rude waiter/
waitress/salesperson
14. Interrupted while talking
15. Was forced to socialize
16. Someone broke a promise/
appointment
17. Competed with someone
18. Was stared at
19. Did not hear from someone
you expected to hear from
20. Experienced unwanted physical
contact (crowded, pushed)
21. Was misunderstood
22. Was embarrassed
23. Had your sleep disturbed
24. Forgot something
25. Feared illness/pregnancy
26. Experienced illness/physical
discomfort
27. Someone borrowed something
without your permission
28. your property was damaged
29. Had minor accident (broke
something, tore clothing)
30. Thought about the future
31. Ran out of food/personal
article

3 =* caused a little stress
4 = caused some stress
5 = caused much stress

6 * caused very
much stress
7 = caused me to
panic

32. Argued with spouse/boyfriend/
girlfriend
___
33. Argued with another person
____
34. Waited longer than you wanted
____
35. Interrupted while thinking/
relaxing
___
36. Someone "cut" ahead of you in
a line
____
37. Performed poorly atsport/game
___
38. Did something that you did not
want to do
___
39. Unable to complete all plans
for today___________________________
40. Had car trouble
____
41. Had difficulty in traffic
___
42. Money problems
_ _
43. Store lacked a desired item
____
44. Misplaced something
_ _
45. Bad weather
____
46. Unexpected expenses (fines,
traffic ticket, etc.)________________
47. Had confrontation with an
authority figure________________ ____
48. Heard some bad news
____
49. Concerned over personal appearance
50. Exposed to feared situation or
object
___
51. Exposed to upsetting TV show,
movie, book
_ _
52. "Pet peeve" violated (someone
fails to knock, etc.)____________ ___ '
53.'Failed to understand something
___
54. Worried about another's problems ___
55. Experienced narrow escape from
danger.____________________________
56. Stopped unwanted personal habit
(overeating, smoking, nailbiting) ___
57. Had problem with kid(s)
___
58. Was late for work/appointment
___
Any stressors that we missed? (list below)
59.
60. ~ ~

,

Daily Symptom Record

PATE

Name:
1.

2.

i
1

j.

WHEEZE TODA Y : N o n e ......................................................0
0-4 ho u r s............................................... 1
4-8 ho u r s ................................................ 2
8-12 ho u r s............................................... 3
12-16 ho u r s............................................. 4
_________ _ _
16 hours or m o r e ..........
««5
ACTIVITY TO U A i :

COUCH TO D A Y :

A n p e n d ix

ffl 4.

LAST NIt;iir: Cood night, did not wake up at a l l ...................... U
Woke up 1-2 Limes due
to wheezing, coughing............ 1
Woke up 3-4 limes due
to wheezing, coughing............ 2
Wuke up 5-6 times due
to wheezing, couching............ 3
Vcrv had night, awake all or most ot' r.ijjht............. 4

5.

6.

0

7.

None .........................
0
Morning o n l y ............................................. I
Evening o n l y ............................................. 2
All d a y ...................................................3
^Indicate whether coughing p r o d m eu ;:nutu:r.-Yes or No___

O

INTERFERENCE U'llil ACTIVITY: How many times did you have to stop
"during an activity or eliminate an activity because* your asthma
was interfering with what you could do? Once y»m record how many
times this happened, write what ihese activities were on the back.
None .....................................................................0
1-2 times............................................................... I
J-4 times............................................................... 2
5-6 times............................................................... 3
6 times or more, could not Jo anything all Ja y......................4
Rate on the following scale how much discomfort your asthma caused today.

I

NONE

Normal, activities not restricted at a l l .......... 0
Slightly restricted, but able tu perform
most of my usual activities......................... 1
Fairly restricted, had to limit some activities...2
Aloe restricted, had to limit must activities
3
Extremely restricted, had co ^et n u i d i c a l h e l ^ ^ ^ 4

2

3

4

5

6 ”

NO MORE
THAN USUAL

Huw man" v igar**”:tov» did *'*>u smoke tod-v ’

8

”

9~

10
WORST
DAY EVER
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Appendix E

—

"MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF SEVERE ASTHMATICS"
,RHONE-NO-<5041-358-1060 ., - ., », v
INFORMED CONSENT
'
. V ;

I,
. , understand th a t I have a serious condition
called bronchial asthma. This has been thoroughly explained to me by my doctors. I
freely and w illingly consent to be a p a rticip a n t In a research project th a t 1s
Investigating a m ultidisciplinary approach to the management of bronchial asthma. The
project is being directed by Or. J . 0. Martin, Associate Professor of Medicine,
Louisiana State University School of Medicine.
As a research subject, I have been asked to:
a)

Undergo a thorough medical examination.

b)

P a rticip ate In a psychological assessment procedure during which I will
be administered the Asthma Symptom Checklist, the Respiratory Illn e ss
Opinion Survey, the Minnesota Multi phasic Personality Inventory, and a
general information questionnaire. This will take a t le a s t two hours
to complete.

c)

P articip ate 1n a group treatment program conducted by the
Earl K. Long Respiratory Department and Psychology Service.

d)

Keep dally records as to my asthma symptoms and the medication I take.

e)

Keep daily records as to the stressfu l events th a t I experience
throughtout the day. I w ill be provided a form on which to record th is
Information.

f)

Agree to p a rtic ip a te 1n future follow-up in v estigations.

I understand that the risk s Involved are no more than those associated with being a
p atien t under normal circumstances. I am aware th a t my doctors will do everything
possible to prevent complications but these s t i l l may occur. The costs of unforeseen
complications must be met by me.
I understand that I may withdraw my p a rticip atio n a t any time without
consequences. In addition, any Information th a t I provide will be kept In confidence.
I f th is information is presented publlcally (journal a r tic le s , conferences,), no
Information will be id en tified with me personally.
I rea liz e th a t I have the rig h t to ask questions a t any time and to have these
questions answered to my s a tisfa c tio n .
I have read and thoroughly understand th is consent form and I have been given a
copy for my records.
I agree to permit the Food and Drug Administration to review my medical records.

Participant

Witness

Date
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